Otology: Special Paper in Celebration of Prof. Yang'S 50 Years Career in Medicine
Otology: Special Paper in Celebration of Prof. Yang'S 50 Years Career in Medicine
Otology: Special Paper in Celebration of Prof. Yang'S 50 Years Career in Medicine
unless there is evidence of auditory nerve damage, the children. It may be diagnosed at newborn times and
term "auditory neuropathy" may not be appropriate. should be suspected in children failing hearing screening
They propose the use of a broader definition of "nerve or deemed at high risk.
conduction disease" [10]. Others have proposed using the Etiologies leading to AN clinical presentations may in-
double meaning term "auditory neuropathy/auditory clude neonatal hyperbilirubinemia, degenerative neural
dys-synchronization (or AN/AD)" [4, 11]. At the Internal diseases, metabolic neural diseases, hereditary motor
Conference on Diagnosis and Intervention of Auditory neuron diseases, demyelination diseases, inflammatory
Neuropathy in Italy in 2008, a guide line for differential neural diseases, ischemic/hypoxic neuropathy, cerebral
diagnosis and intervention of AN in children was pro- edema, cerebral palsy, abnormal release of neurotrans-
posed, which named this class of diseases as"auditory mitters, infectious diseases (e.g. parotiditis), autoim-
neuropathy spectrum disorder"(or ANSD) [12, 13]. The two mune diseases and development retardation. From the
mainstream terms at this time are AN and ANSD. In latest literature, neonatal hyperbilirubinemia and hypox-
consideration of its broad use in the clinic, AN is used in ia are the most important risk factors [18]. Gene mutation
this report to refer to the condition in this group of pa- is another major cause for some AN phenotypes, espe-
tients. cially in AN children with non-syndromic pre-lingual
deafness.
Epidemiology and etiology of AN
AN clinical audiology characteristics and
Summarized in Table 1 are epidemiology reports regard- diagnosis
ing AN in the literature. It shows that the rate of AN is
about 7% to 13.4% (average 10%) among children with Currently, reported clinical characteristics vary greatly
confirmed diagnosis of severe or profound hearing loss [5, among AN patients. Clinically, compromise of auditory
14-19]
, with a matched gender ratio [19, 20]. When the average nerve activities are represented by abnormal or absent
hearing screened newborn population is used, the rate ABRs, absence or elevated thresholds in acoustic reflex
falls blow 1% [17, 20]. Among all age populations or with absent or weak contralateral inhibition, etc. Cochle-
deaf-mute school students, average rate of AN is below ar function indicators such as otoacoustic emissions
3% [21-24]. These data show that AN rate decreases as (OAEs) and cochlear microphonic (CM) are usually nor-
patient age increases. From this, it is speculated that AN mal. There are also unique psychophysical presentations.
may be a condition related to hereditary and/or peri-natal Clinical complaints or functional hearing loss in AN
factors and may be present in about 10% of high risk patients are reflected mainly through psychophysical
1999 Rance et al [20] Children with severe or profound hearing loss 1/9 11.100
2002 Siniger et al [26] Patients in NIDCD sponsored newborn hearing screening Review 10.00
[21]
2005 Cheng et al Students in US deaf and mute schools 76/777 9.78
2006 Foerst et al [23] Children with severe SNHL 32/379 8.44
2008 Vlastarakos et al [24] Children with confirmed hearing loss Meta-analysis 8.00
[7]
2009 Sanyelbhaa Children with severe or profound hearing loss 15/112 13.40
[8]
2010 Berlin et al Children with hearing loss Review >10.00
[27]
2009 Dowley et al Children with severe SNHL 12/30 40.00
2006 Foerst et al [23] Average newborns 32/3415 0.94
87
2012 Vol.7 No.2
testing. Because psychophysical testing requires cooper- rooms for debate over if AN can be diagnosed based on
ation by the patient, its results are available only from CM linearity data.
older children and adults. Among AN patients reported Simultaneous presence of the two indicators discussed
in the literature, pure tone hearing loss ranges from mild above is a necessary requirement (inclusion criteria) for
to profound, although mild and moderate in most cases. differentiation from other sensorineural hearing loss and
Audiogram patterns are also variable, although dominat- diagnosis of AN. Almost all AN subjects in the reported
ed by ascending patterns [25]. Speech discrimination dis- literature have been identified using these two condi-
orders are the most difficult for AN patients, typically tions [5]. Combined testing of ABRs, CM and OAEs pro-
showing unproportionally poor discrimination contrasted vides information regarding diseases locations along the
to pure tone thresholds, especially in noise [4, 26]. Middle auditory pathways including OHCs, auditory nerve and
ear muscle reflex and olivocochlear reflex are important brainstem, although there still lacks means to identify
to hearing in noise. These are compromised in AN pa- diseases at IHCs and pre- or post-synaptic locations.
tients, i.e. loss of efferent inhibition. This may explain
the poor speech discrimination in noise. Zeng et al Electrophysiological characteristics of AN
found that AN patients had decreased sensitivity to tem-
poral envelop fluctuation and speculated that speech dis- The CM, summiting potential (SP), compound action
crimination difficulties in AN patients might be related potential (CAP) and central auditory evoked potentials
to compromised temporal processing [3]. Compromised (CAEPs) in AN patients all have distinct features that
timing cue perception may affect low frequency discrimi- can be used to differentiate sub-types of AN and facili-
nation, temporal separation perception, timing integra- tate clinical diagnosis and intervention.
tion, temporal modulation perception, forward and back- Starr [29] and Santarelli [30] found that click induced CM
ward masking, signal recognition in noise, binaural beat, in AN children is abnormally large in amplitude. SHI
interaural temporal difference based sound localization, Wei et al [28] concluded that non-linearity in CM I/O
etc. On the other hand, intensity cue perception, such as curve indicates intact OHCs but is insufficient to deter-
intensity discrimination and interaural intensity differ- mine the status of IHCs.
ence based sound localization, is no different in AN pa- Round window electrocochleography (RW ECoG) us-
tients from normal individuals [27]. es transtympanic electrode to record cochlear responses
Among existing diagnostic criteria for AN, the only and provides increased details in information regarding
widely accepted mandatory one is "absent or abnormal the cochlea and VIIIth cranial nerve. Studying the SP
ABRs", which represents disruption to synchronicity in and AP in RW ECoG in conjunction with observation of
activities along the auditory pathway. All patients includ- abnormal positive potential (APP) [30] or dentritic poten-
ed in AN studies so far show this presentation. Abnor- tial (DP) [31] may help locating the AN disease site.
mal ABRs in AN usually refer to inappropriate ABR O'Leary et al were the first to report SP with delayed
morphology or thresholds not anticipated based upon latencies and increased amplitudes (i.e. APP) on RW
pure tone thresholds. This is probably the most distinct ECoG in some children with profound hearing loss [32].
clinical feature in AN. Another necessary presentation is Santarelli [30] and McMahon et al [31] later also recorded
"intact OHC function", as represented by existence of APP in some AN children. Santarelli divided RW ECoG
OAEs or CM or both. It is widely accepted that OAEs findings in AN patients into three groups: 1) presence of
originate from OHCs, but whether CM is solely from both SP and CAP, indicating postsynaptic lesions at prox-
OHCs or may contain contributions from IHCs is still imal auditory nerve endings; 2) presence of SP with
being debated. Because of this, when OAEs are not pres- absence of CAP, indicating pre-synaptic lesions at IHCs;
ent, CM may not be the definite indication of "intact and 3) increased SP amplitude with delayed latencies (or
OHC function". Some believe that the linearity of CM APP) and no CAP, representing pre-synaptic lesions, per-
input/output (I/O) curve reflects the presence of OHCs haps from compromised neurotransmitter release pro-
[28] and that perfect linearity represents loss of OHC cess [30]. McMahon et al [31] believed that APP represent-
compression functions and only contributions from ed pre-synaptic damage, but the mechanisms may be
IHCs. On the other hand, non-linearity in CM I/O similar to that causing increased SP amplitude in pa-
curves indicates intact OHC function, although this does tients with endolymphatic hydrops (i.e. bias shift of IHC
not necessarily provide information on IHCs. Used togeth- cilia toward an "off" position). In their study, SP latency
er with ABR results, OAEs can be an important indicator was normal, followed by a long negative potential, in
of AN. However, linearity measurement has not been some AN patients, which was considered as a DP indicat-
quantified and its relations with OHC function have not ing post-synaptic damage. In general, presence of APP
been confirmed by laboratory or clinical data, leaving appears to indicate pre-synaptic damage or damage to
88
2012 Vol.7 No.2
Particular pathological changes that can potentially dis- grossly abnormal while OAEs are present. Auditory
rupt or lower neural conduction synchronicity include pathway dysfunction related to this gene involves only
mechanical changes in hair cells, metabolic changes loss of the spiral ganglion, with no peripheral or cranial
within hair cells, compromised release and re-uptake of nerve neuropathy.
neurotransmitters, decrease in receptor sensitivity and These animal models have served to guide clinical
impaired discharge initiation at nerve endings, as well as treatment for AN, i.e. cochlear implant can be expected
pathologies involving neurotransmitters, axons and my- to produce good results in patients with presentations
elin sheath. corresponding to animal models of IHC and synaptic le-
At this time, the best evidence to support existence of sions, whereas it usually fails in those with presentations
AN is presence of accompanying peripheral or cranial corresponding to models of auditory nerve or central au-
nerve neuropathy. If such neuropathy is absent and there ditory pathway damages.
is clear auditory responses to electrical stimulation,
nerve ending-IHC or synaptic lesions are speculated as References
the etiology. Synaptic lesions may involve temporal pro-
cessing changes, discharge amplitude changes and affer- [1] Starr A, Picton TW, Sininger Y, et al. Auditory neuropathy.
ent nerve receptor changes. In addition, gene mutations Brain 1996, 119 (3):741-53.
[2] Satrr A, McPherson D, Patterson J, et al. Absence of both audi-
that have been shown to be related to AN through genet-
tory evoked potentials and auditory percepts dependent on timing
ic screening need to be further studied to clarify the loca- cues. Brain 1991,114:1157-1180.
tions and pathological mechanisms in AN (see below). [3] Zeng FG, Oba S, Garde S, et al . Temporal and speech pro-
cessing deficits in auditory neuropathy. Neuroreport 1999,10:
The role of basic research in diagnosis 3429-3435.
and treatment of AN [4] Berlin CI, Hood L, Morlet T, et al . Auditory neuropathy/
dys-synchrony: diagnosis and management. Ment Retard Dev Dis-
abil Res Rev 2003,9:225-231.
Animal studies at cellular and molecular levels may
[5] Berlin CI, Hood LJ, Morlet T, et al. Multi-site diagnosis
provide directions for description and detection of AN le- and management of 260 patients with auditory neuropathy/
sion sites and for development of treatments. dys-synchrony (auditory neuropathy spectrum disorder). Int J Au-
Animal models with known lesion locations at the diol 2010, 49:30-43.
IHC and synapses include: 1) Cav1.3 ion channel knock- [6] Sarr A, Zeng FG, HJ M. Perspective on Auditory Neuropa-
out mice [36, 37], in which neurotransmitter release from thy: Disorders on Inner Hair Cell, Auditory Nerve, and Their Syn-
IHCs is blocked, with 90% decrease in Ca2 + current [38], apse. In: Allan I. Basbaum, Akimichi Kaneko, Gordon M. Shep-
herd, Westheimer G, editors. The Senses: A comprehensive Refer-
absent ABRs, but preserved high frequency DPOAEs; 2)
ence, vol. 3. San Diego: Elsevier, 2008, 397-412.
Bassoon protein (a structural protein responsible for lo- [7] Worthington D, Peters J. Quantifiable hearing and no ABR:
cating ribbon synapse to IHC active pre-synaptic area) paradox or error? . Ear Hear 1980,1:281-285.
mutation mice, in which numbers of synapses and synap- [8] Kraus N, Ozdamar O, Stein L, et al. Absent auditory brain
tic release vesicles are reduced [39], with slightly de- stem response: peripheral hearing loss or brain stem dysfunc-
creased Ca2 + current, abnormal ABRs, but normal CM tion? . Laryngoscope 1984, 94:400-406.
and DPOAEs; and 3) OTOF gene (coding the otoferlin [9] Gu Rui, Yu Li-Ming. The Function of Medial Olivocochle-
protein which is closely related to the release of ribbon ar System in Patients with Central Low. Chinese Journal of Otorhi-
nolaryngology Head and Neck Surgery . 1992, 27:27-29.
synaptic vesicles [40]) knockout mice, in which the ribbon
[10] Rapin I, Gravel JS. Auditory neuropathy: a biologically in-
synapse morphology and Ca2 + current are both normal, appropriate label unless acoustic nerve involvement is document-
but IHC neurotransmitter release is decreased with ab- ed. J Am Acad Audiol 2006,17:147-150.
sent ABRs but normal OAEs or CM. [11] Berlin C, Hood I, Rose K. On renaming auditory neuropa-
Animal models with known lesion locations at the syn- thy as auditory dys-synchrony. Audiol Today 2001, 13:15-17.
apse or auditory nerve include: 1) Beta-4 (a protein play- [12] Sininger Y, Starr A, Petic C, et al. Guidelines for Identifica-
ing an important role in locating and linking the volt- tion and Management of Infants and Young Children with Audito-
ry Neuropathy Spectrum Disorder. Guidelines Development Con-
age-gated sodium and potassium channels at the node of
ference on the Identification and Management of Infants and
Ranvier [41]) gene mutation mice, in which only Wave I Young Children with Auditory Neuropathy. Como, Italy, 2008.
can be induced in some animals with progressive latency [13] Roush P, Frymark T, Venediktov R, et al. Audiologic man-
delay; 2) myelin sheath protein gene (PMP22) defect ani- agement of auditory neuropathy spectrum disorder in children: a
mals, in which ABR waves show low amplitudes and de- systematic review of the literature. Am J Audiol 2011,20:159-170.
layed latencies and abnormal myelin sheath formation [14] Sanyelbhaa Talaat H, Kabel AH, Samy H, et al. Prevalence
and progressive loss of spiral ganglion [42]; and 3) erbB of auditory neuropathy (AN) among infants and young children
sensor defect animals, in which ABRs are absent or with severe to profound hearing loss. Int J Pediatr Otorhinolaryn-
gol 2009,73:937-939.
90
2012 Vol.7 No.2
[15] Rance G, Beer DE, Cone-Wesson B, et al. Clinical findings [30] Santarelli R, Starr A, Michalewski HJ, et al. Neural and re-
for a group of infants and young children with auditory neuropa- ceptor cochlear potentials obtained by transtympanic electroco-
thy. Ear Hear 1999, 20:238-252. chleography in auditory neuropathy. Clin Neurophysiol,2008,
[16] Cheng X, Li L, Brashears S, et al. Connexin 26 variants and 119:1028-1041.
auditory neuropathy/dys-synchrony among children in schools for [31] McMahon CM, Patuzzi RB, Gibson WP, et al. Frequen-
the deaf. Am J Med Genet A 2005,139:13-18. cy-specific electrocochleography indicates that presynaptic and
[17] Foerst A, Beutner D, Lang-Roth R, et al. Prevalence of audi- postsynaptic mechanisms of auditory neuropathy exist. Ear Hear,
tory neuropathy/synaptopathy in a population of children with pro- 2008,29:314-325.
found hearing loss. Int J Pediatr Otorhinolaryngol 2006,70: [32] O'Leary S, Mitchell T, Gibson W, et al. Abnormal positive
1415-1422. potentials in round window electrocochleography. Am J Otolaryn-
[18] Vlastarakos PV, Nikolopoulos TP, Tavoulari E, et al. Audito- gol ,2000, 21:813-818.
ry neuropathy: endocochlear lesion or temporal processing impair- [33] Gibson WP, Sanli H. Auditory neuropathy: an update. Ear
ment? Implications for diagnosis and management. Int J Pediatr Hear,2007,28:102S-106S.
Otorhinolaryngol 2008,72:1135-1150. [34] Rance G, Cone-Wesson B, Wunderlich J, et al. Speech per-
[19] Sininger Y. Auditory neuropathy in infants and children: Im- ception and cortical event related potentials in children with audi-
plicatons for early hearing detection and intervention programs. tory neuropathy. Ear Hear,2002, 23:239-253.
Audiol Today 2002, 14:16-21. [35] Pearce W, Golding M, Dillon H. Cortical auditory evoked
[20] Dowley AC, Whitehouse WP, Mason SM, et al. Auditory potentials in the assessment of auditory neuropathy: two case stud-
neuropathy: unexpectedly common in a screened newborn popula- ies. J Am Acad Audiol ,2007, 18:380-390.
tion. Dev Med Child Neurol 2009, 51:642646. [36] Platzer J, Engel J, A AS-F, et al. Congenital deafness and si-
[21] Kumar UA, Jayaram MM. Prevalence and audiological noatrial node dysfunction in mice lacking class D L-type Ca2 +
characteristics in individuals with auditory neuropathy/auditory channels. Cell ,2000,102:89-97.
dys-synchrony. Int J Audiol 2006,45:360-366. [37] Dou H, Vazquez A, Namkung Y, et al. Null mutation of al-
[22] Tang TP, McPherson B, Yuen KC, et al. Auditory neuropa- pha1D Ca2+ channel gene results in deafness but no vestibular de-
thy/auditory dys-synchrony in school children with hearing loss: fect in mice. J Assoc Res Otolaryngol , 2004,5:215-226.
frequency of occurrence. Int J Pediatr Otorhinolaryngol ,2004,68: [38] Brandt A, Striessnig J, T TM. CaV1.3 channels are essential
175-183. for development and presynaptic activity of cochlear inner hair
[23] Lotfi Y, Mehrkian S. The prevalence of auditory neuropathy cells. J Neurosci ,2003,23:10832-10840.
in students with hearing impairment in Tehran, Iran. Arch Iran [39] Khimich D, Nouvian R, Pujol R, et al. Hair cell synaptic rib-
Med ,2007, 10:233-235. bons are esssential for synchronous auditory signaling. Nature
[24] Lee JS, McPherson B, Yuen KC, et al. Screening for audito- 2005; 434:889-894.
ry neuropathy in a school for hearing impaired children. Int J Pedi- [40] Roux I, Safieddine S, Nouvian R, et al. Otoferlin, defective
atr Otorhinolaryngol,2001,61:39-46. in a human deafness form, is essential for exocytosis at the audito-
[25] Ji Fei, Chen Ai-Ting, Zhao Yang et al. An analysis of the ry ribbon synapse. Cell 2006, 127:277-289.
Performance-Intensity function of patients with auditory neuropa- [41] Bennet V, Baines A. Spectrin and ankyrin-based pathways:
thy. Chinese Scientific Journal of Hearing and Speech Rehabilita- metazoan inventions for integrating cells into tissues. Physiol
tion ,2010:23-26. Rev ,2001,81:1353-1392.
[26] Rance G, Barker EJ, Sarant JZ, et al. Receptive language [42] Zhou R, Assouline J, Abbas P, et al. Anatomical and physio-
and speech production in children with auditory neuropathy/dys- logical measures of auditory system in mice with peripheral my-
synchrony type hearing loss. Ear Hear,2007,28:694-702. elin deficiency. Hear Res,1995,88:87-97.\
[27] Zeng FG, Kong YY, Michalewski HJ, et al. Perceptual con-
sequences of disrupted auditory nerve activity. J Neurophysiol , (Rrceived August 8,2012)
2005,93:3050-3063.
[28] Shi W, Ji F, Lan L, et al. Characteristics of cochlear micro-
phonics in infants and young children with auditory neuropathy.
Acta Otolaryngol ,2011,132:188-196.
[29] Starr A, Sininger Y, Nguyen T, et al. Cochlear receptor (mi-
crophonic and summating potentials, otoacoustic emissions) and
auditory pathway (auditory brain stem potentials) activity in audi-
tory neuropathy. Ear Hear ,2001, 22:91-99.
91